SYNAPTOGENIX, INC.
1185 Avenue of the Americas, 3rd Floor
New York, New York 10036
October 17, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Hamill
| Re: | Synaptogenix, Inc. |
Registration Statement on Form S-3
Filed October 10, 2024
File No. 333-282589 (the “Registration Statement”)
Acceleration Request
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Synaptogenix, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement to Monday, October 21, 2024, at 4:00 p.m., Eastern Time, or as soon as thereafter practicable.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please contact Daniel A. Bagliebter of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any questions regarding this request.
| Very truly yours, | |
| SYNAPTOGENIX, INC. | |
| /s/ Robert Weinstein | |
| Robert Weinstein | |
| Chief Financial Officer, Secretary and Executive Vice President |
| cc: | Mintz, Levin. Cohn. Ferris. Glovsky and Popeo. P.C |
Kenneth R. Koch, Esq.
Daniel A. Bagliebter, Esq.